Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis

Clinical trial NCT07205081 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07205081
Sponsor: Attovia Therapeutics Inc
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Volunteers Atopic Dermatitis (AD)Atopic Eczema Atopic Eczema/Dermatitis (Non-Specific)

Start date: 2025-10-22
Primary completion: 2026-10-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.